BRUSSELS (Reuters) – U.S. enterprise software program maker Oracle Corp (NYSE:) has secured unconditional EU antitrust clearance for its $28.3 billion acquisition of U.S. healthcare IT firm Cerner Corp (NASDAQ:), the EU competitors enforcer stated on Thursday.

The acquisition, Oracle’s largest ever, would give the corporate entry to a trove of information and will improve the variety of healthcare purchasers to its cloud platform.

The European Fee stated it didn’t have any competitors issues in regards to the deal as there are not any overlaps between the businesses and the merged firm wouldn’t have the flexibility to close out rivals.

Reuters reported completely on Might 24 that Oracle would get the EU inexperienced mild.